Dr. Eric Singer on Kidney Cancer Treatment Advances, Breaking Research, and the KCA

3 Views
Published
Dr. Eric Singer is a urologic oncologist at The Ohio State University. Dr. Singer shares his thoughts on kidney cancer treatment advances, what we learned and can apply from the PROSPER trial, thinking carefully about “what we could do and what we should do,” and getting more precise in the adjuvant treatment of the disease. Dr. singer also touches on how care team communication is a “team sport” within his institution and with community partners. Dr. Singer is also a member of the Kidney Cancer Association's Medical Steering Committee and he shares more about his involvement with advocacy groups as well as the KCA's biannual International Kidney Cancer Symposiums.

Video filmed in partnership with Topline Bio, LLC.
Category
Urology
Be the first to comment